MDL | - |
---|---|
Molecular Weight | 516.59 |
Molecular Formula | C31H28N6O2 |
SMILES | OC(C=C1)=CC([C@@H](C2=C(CNCC3=CC4=C(C=CN4CC5=CN(C)C=N5)C=C3)NC6=CC=CC=C62)N7)=C1C7=O |
BI-2852 is a KRAS inhibitor for the switch I/II pocket (SI/II-pocket) by structure-based drug design with nanomolar affinity. BI-2852 is mechanistically distinct from covalent KRAS G12C inhibitor (binds to switch II pocket) and binds ten-fold more strongly to active KRAS G12D versus KRAS wt (740 nM vs 7.5 μM). BI-2852 blocks GEF, GAP, and effector interactions with KRAS, leading to inhibition of downstream signaling and an antiproliferative effect in KRAS mutant cells [1] .
KRAS(G12C) 450 nM (IC 50 ) |
KRAS(G12C) 750 nM (Kd) |
BI-2852 (Compound 1) (10 nM-10 µM; 2 hours) shows a dose-dependent pERK modulation and antiproliferative effect at EC 50 s of 5.8 µM and 6.7 µM in soft agar and low serum conditions in NCI-H358 cells [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
4°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
DMSO : 55 mg/mL ( 106.47 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 1.9358 mL | 9.6789 mL | 19.3577 mL |
5 mM | 0.3872 mL | 1.9358 mL | 3.8715 mL |
10 mM | 0.1936 mL | 0.9679 mL | 1.9358 mL |